In an effort to address growing concerns about forever chemicals, the U.S. Centers for Disease Control and Prevention (CDC) has released new guidance for clinicians seeking to determine community-wide exposure and diagnose conditions that may be related to high exposure.
Health care providers can order tests to check PFAS blood levels through commercial clinical laboratories certified by Clinical Laboratory Improvement Amendments (CLIA), which regulate lab testing. The results can indicate both recent or past exposure, the CDC said.
